Literature DB >> 21443415

Strategies to enhance viral penetration of solid tumors.

Elspeth Smith1, Jessica Breznik, Brian D Lichty.   

Abstract

The efficient delivery of viral vectors to tumors is an active area of investigation. A number of barriers exist that must be overcome to achieve good penetration of vectors into tumors and distribution of their effects throughout the tumor mass. Replicating oncolytic viruses have the advantage of being able to amplify the initial dose, but progeny virus are prevented from spreading because of a dense mass of tightly packed cells with a dense extracellular matrix, admixed normal stromal cells, and high interstitial pressure. Although intratumoral injection may ensure initial delivery the distribution achieved by intravenous administration may be superior and come with beneficial bystander damage to the tumor vasculature. Strategies to enhance intravenous delivery and subsequent spread of these vectors within tumors are being developed by a number of groups. Achieving the goal of efficient penetration and spread of viruses within solid tumors is a necessary prerequisite to significant improvements in virus-vectored therapy of solid tumors.

Entities:  

Mesh:

Year:  2011        PMID: 21443415     DOI: 10.1089/hum.2010.227

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  27 in total

1.  Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth.

Authors:  Alison Tedcastle; Sam Illingworth; Alice Brown; Leonard W Seymour; Kerry D Fisher
Journal:  Mol Ther       Date:  2015-12-28       Impact factor: 11.454

Review 2.  Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.

Authors:  Jessie L-S Au; Bertrand Z Yeung; Michael G Wientjes; Ze Lu; M Guillaume Wientjes
Journal:  Adv Drug Deliv Rev       Date:  2015-12-11       Impact factor: 15.470

3.  Different modes of herpes simplex virus type 1 spread in brain and skin tissues.

Authors:  Yael Tsalenchuck; Tomer Tzur; Israel Steiner; Amos Panet
Journal:  J Neurovirol       Date:  2014-01-10       Impact factor: 2.643

4.  Recent advances of oncolytic virus in cancer therapy.

Authors:  Moumita Mondal; Jingao Guo; Ping He; Dongming Zhou
Journal:  Hum Vaccin Immunother       Date:  2020-02-20       Impact factor: 3.452

5.  Cell-free transmission of human adenovirus by passive mass transfer in cell culture simulated in a computer model.

Authors:  Artur Yakimovich; Heidi Gumpert; Christoph J Burckhardt; Verena A Lütschg; Andreas Jurgeit; Ivo F Sbalzarini; Urs F Greber
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

6.  Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV.

Authors:  Ji Young Yoo; Jason Pradarelli; Amy Haseley; Jeffrey Wojton; Azeem Kaka; Anna Bratasz; Christopher A Alvarez-Breckenridge; Jun-Ge Yu; Kimerly Powell; Andrew P Mazar; Theodoros N Teknos; E Antonio Chiocca; Joseph C Glorioso; Matthew Old; Balveen Kaur
Journal:  Clin Cancer Res       Date:  2012-07-02       Impact factor: 12.531

7.  Pulsed focused ultrasound exposures enhance locally administered gene therapy in a murine solid tumor model.

Authors:  Ali Ziadloo; Jianwu Xie; Victor Frenkel
Journal:  J Acoust Soc Am       Date:  2013-03       Impact factor: 1.840

Review 8.  Positive and negative influence of the matrix architecture on antitumor immune surveillance.

Authors:  Elisa Peranzoni; Ana Rivas-Caicedo; Houcine Bougherara; Hélène Salmon; Emmanuel Donnadieu
Journal:  Cell Mol Life Sci       Date:  2013-05-07       Impact factor: 9.261

Review 9.  Evolving Role of Oncolytic Virotherapy: Challenges and Prospects in Clinical Practice.

Authors:  Omeed Moaven; Christopher W Mangieri; John A Stauffer; Panos Z Anastasiadis; Mitesh J Borad
Journal:  JCO Precis Oncol       Date:  2021-02-24

10.  Effect of intratumoral administration on biodistribution of 64Cu-labeled nanoshells.

Authors:  Huan Xie; Beth Goins; Ande Bao; Zheng Jim Wang; William T Phillips
Journal:  Int J Nanomedicine       Date:  2012-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.